Little Green Pharma (ASX: LGP) has been on a roll this quarter. Increasing cash receipts by 35% from $4.4 million to $6 million, the Company has made strides in its cannabis operations. The influx of revenue was thanks to the first shipment of new strains from Denmark, which earned more than $0.5 million over five
Read More
Australian medical cannabis company Little Green Pharma (ASX: LGP) has reached a major offtake agreement with Demecan to distribute cannabis products across Germany. With the German medical cannabis market estimated to be worth €7.7bn (A$11.2bn) by 2028, this opportunity marks a massive milestone for the Company. In July 2021, LGP acquired a world-class cultivation site
Read More
January is normally a quiet month for IPOs and this year has been no different, but here are a few companies intending to list on the ASX in February which may be worth keeping an eye on. ARMnet Limited (Proposed ASX: AR1) Financial Services Software Company, ARMnet Limited, are proposing to list on the ASX
Read More